Patent ID: 8859557

Claim:
A method for the treatment of at least one disorder selected from the group consisting of anxiety disorders and/or stress-dependent anxiety disorders, depressive disorders, arterial hypertension, pulmonary hypertension, and congestive heart failure (CHF), characterized in that an effective amount of at least one compound of the general formula (I) or at least one pharmaceutically acceptable salt, or one tautomeric form thereof, is administered to a patient in need thereof, in which R1 is ethoxy; R2 is hydrogen; R3 is cyano; R4 is hydrogen; R5 is hydrogen, methoxy or ethoxy; R6 is hydrogen or methoxy; R7 is hydrogen, methyl, ethyl, n-propyl or isopropyl; X1 is —NH—; X2 is N or CH; and X3 is N or CH; where X2 and X3 are not simultaneously N.